European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“In the ESMO Daily Reporter, Umberto Malapelle explains how concomitant analysis of DNA and RNA can advance cancer characterisation and guide clinical decision making. He highlights findings presented at ESMO Asia25, which involved the comprehensive genomic and transcriptomic characterisation of MTAP loss across different solid tumours.
Read more in his Opinion piece.”
More from European Society for Medical Oncology.